ZA978303B - Medicinal aerosol formulations - Google Patents

Medicinal aerosol formulations

Info

Publication number: ZA978303B
Authority: ZA; South Africa
Prior art keywords: aerosol formulations; medicinal aerosol; medicinal; formulations; aerosol
Prior art date: 1996-09-27

Application number

ZA978303A

Other languages

English (en)

Inventor

Nayna Govind

Danna Louise Ross

Philip Anthony Jinks

Gary Henry Ward

Original Assignee

Minnesota Mining & Mfg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-27

Filing date

1997-09-15

Publication date

1999-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10800599&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA978303(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-09-15 Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg

1999-03-15 Publication of ZA978303B publication Critical patent/ZA978303B/xx

Links

239000000443 aerosol Substances 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dispersion Chemistry (AREA)
Immunology (AREA)
Otolaryngology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA978303A 1996-09-27 1997-09-15 Medicinal aerosol formulations ZA978303B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9620187.6A GB9620187D0 (en)	1996-09-27	1996-09-27	Medicinal aerosol formulations

Publications (1)

Publication Number	Publication Date
ZA978303B true ZA978303B (en)	1999-03-15

Family

ID=10800599

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA978303A ZA978303B (en)	1996-09-27	1997-09-15	Medicinal aerosol formulations

Country Status (21)

Country	Link
EP (1)	EP0932397B2 (xx)
JP (1)	JP2001501209A (xx)
KR (1)	KR20000048646A (xx)
AR (1)	AR009370A1 (xx)
AT (1)	ATE320246T1 (xx)
AU (1)	AU732985B2 (xx)
BR (1)	BR9712125A (xx)
CA (1)	CA2266431A1 (xx)
CZ (1)	CZ102799A3 (xx)
DE (1)	DE69735497T2 (xx)
ES (1)	ES2259447T3 (xx)
GB (1)	GB9620187D0 (xx)
HU (1)	HUP0000795A3 (xx)
ID (1)	ID22523A (xx)
MY (1)	MY130946A (xx)
NO (1)	NO991407L (xx)
PL (1)	PL332422A1 (xx)
PT (1)	PT932397E (xx)
SK (1)	SK38399A3 (xx)
WO (1)	WO1998013031A2 (xx)
ZA (1)	ZA978303B (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5863910A (en) *	1996-01-12	1999-01-26	Bolonick; Joel	Treatment of chronic inflammatory disorders of the gastrointestinal tract
US20010031244A1 (en)	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
US6433040B1 (en)	1997-09-29	2002-08-13	Inhale Therapeutic Systems, Inc.	Stabilized bioactive preparations and methods of use
US6946117B1 (en)	1997-09-29	2005-09-20	Nektar Therapeutics	Stabilized preparations for use in nebulizers
US20060165606A1 (en)	1997-09-29	2006-07-27	Nektar Therapeutics	Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en)	1997-09-29	2003-05-20	Inhale Therapeutic Systems, Inc.	Methods of spray drying pharmaceutical compositions
US6309623B1 (en)	1997-09-29	2001-10-30	Inhale Therapeutic Systems, Inc.	Stabilized preparations for use in metered dose inhalers
DZ2947A1 (fr)	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
IT1303788B1 (it)	1998-11-25	2001-02-23	Chiesi Farma Spa	Formulazioni di aerosol medicinali.
US6315985B1 (en)	1999-06-18	2001-11-13	3M Innovative Properties Company	C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it)	1999-07-23	2002-09-09	Chiesi Farma Spa	Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
GB9925934D0 (en) *	1999-11-03	1999-12-29	Glaxo Group Ltd	Novel apparatus and process
IT1317846B1 (it)	2000-02-22	2003-07-15	Chiesi Farma Spa	Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
ES2525087T5 (es)	2000-05-10	2018-06-28	Novartis Ag	Polvos basados en fosfolípidos para administración de fármacos
US7871598B1 (en)	2000-05-10	2011-01-18	Novartis Ag	Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
ME00220B (me)	2000-05-22	2010-10-10	Chiesi Farm Spa	Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
PT1273292E (pt)	2001-07-02	2004-10-29	Chiesi Farma Spa	Formulacao optimizada de tobramicina para aerossolizacao
ES2364636T3 (es)	2001-12-19	2011-09-08	Novartis Ag	Administración pulmonar de aminoglucósidos.
GB0311701D0 (en) *	2003-05-21	2003-06-25	Karib Kemi Pharm Liited	Improved metered dose inhaler product
EP1595531A1 (en)	2004-05-13	2005-11-16	CHIESI FARMACEUTICI S.p.A.	Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1949891A1 (en) *	2004-10-12	2008-07-30	Generics (UK) Limited	Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
CA2581999C (en) *	2004-10-12	2013-04-23	Generics (Uk) Limited	Preparation of suspension aerosol formulations
ES2259915B1 (es) *	2005-03-15	2007-12-16	Laboratorio Aldo-Union, S.A.	Nueva formulacion estable de aerosoles en suspension y procedimiento de obtencion.
TW201010708A (en) *	2008-06-02	2010-03-16	Intervet Int Bv	Composition comprising an antibiotic and a corticosteroid
CN103655473A (zh) *	2011-10-27	2014-03-26	江苏长风药业有限公司	以氢氟烷烃为抛射剂的布地奈德气雾剂制剂
CN102362859A (zh) *	2011-10-27	2012-02-29	江阴长风医药科技有限公司	以氢氟烷烃为抛射剂的布地奈德气雾剂制剂
CN109646400A (zh) *	2018-12-25	2019-04-19	上海信谊百路达药业有限公司	一种布地奈德吸入气雾剂及其制备方法
CN112891328A (zh) *	2021-04-12	2021-06-04	上海方予健康医药科技有限公司	一种吸入用布地奈德混悬液的制备方法
CN113768906B (zh) *	2021-10-25	2023-05-09	上海方予健康医药科技有限公司	新型糖皮质激素吸入气雾剂及药物组件

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8828477D0 (en) †	1988-12-06	1989-01-05	Riker Laboratories Inc	Medical aerosol formulations
DE4003272A1 (de) †	1990-02-03	1991-08-08	Boehringer Ingelheim Kg	Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US5136107A (en) *	1990-06-04	1992-08-04	Ethyl Corporation	Process for halogenating aromatic compounds
EP0504112A3 (en) *	1991-03-14	1993-04-21	Ciba-Geigy Ag	Pharmaceutical aerosol formulations
PT717987E (pt) †	1991-12-18	2001-12-28	Minnesota Mining & Mfg	Formulacoes de suspensao em aerossol
DE4230876A1 (de) †	1992-03-17	1993-09-23	Asta Medica Ag	Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
CA2156408C (en) *	1993-03-17	2005-02-15	Daniel C. Duan	Aerosol formulation containing a polyester dispersing aid
DE4322703A1 (de) *	1993-07-08	1995-01-12	Asta Medica Ag	Druckgaspackungen unter Verwendung von Polyoxyethylen-glyceryl-fettsäureestern als Suspensionsstabilisatoren und Ventilschmiermittel
TW283164B (xx) *	1993-09-24	1996-08-11	Du Pont
US5508023A (en) *	1994-04-11	1996-04-16	The Center For Innovative Technology	Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
GB9425160D0 (en) †	1994-12-10	1995-02-08	Glaxo Group Ltd	Medicaments
CZ288146B6 (en) *	1994-12-22	2001-05-16	Astra Ab	Pharmaceutical aerosol preparation, process of its preparation and use

1996
- 1996-09-27 GB GBGB9620187.6A patent/GB9620187D0/en active Pending
1997
- 1997-09-15 ZA ZA978303A patent/ZA978303B/xx unknown
- 1997-09-23 AT AT97943453T patent/ATE320246T1/de not_active IP Right Cessation
- 1997-09-23 KR KR1019990702589A patent/KR20000048646A/ko not_active Withdrawn
- 1997-09-23 AU AU44926/97A patent/AU732985B2/en not_active Ceased
- 1997-09-23 HU HU0000795A patent/HUP0000795A3/hu unknown
- 1997-09-23 DE DE69735497T patent/DE69735497T2/de not_active Expired - Lifetime
- 1997-09-23 CZ CZ991027A patent/CZ102799A3/cs unknown
- 1997-09-23 JP JP10515789A patent/JP2001501209A/ja active Pending
- 1997-09-23 CA CA002266431A patent/CA2266431A1/en not_active Abandoned
- 1997-09-23 EP EP97943453.7A patent/EP0932397B2/en not_active Expired - Lifetime
- 1997-09-23 ID IDW990102D patent/ID22523A/id unknown
- 1997-09-23 PL PL97332422A patent/PL332422A1/xx unknown
- 1997-09-23 ES ES97943453T patent/ES2259447T3/es not_active Expired - Lifetime
- 1997-09-23 BR BR9712125-8A patent/BR9712125A/pt unknown
- 1997-09-23 SK SK383-99A patent/SK38399A3/sk unknown
- 1997-09-23 WO PCT/US1997/016869 patent/WO1998013031A2/en active IP Right Grant
- 1997-09-23 PT PT97943453T patent/PT932397E/pt unknown
- 1997-09-26 AR ARP970104440A patent/AR009370A1/es not_active Application Discontinuation
- 1997-09-27 MY MYPI97004533A patent/MY130946A/en unknown
1999
- 1999-03-23 NO NO991407A patent/NO991407L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
PL332422A1 (en)	1999-09-13
HUP0000795A2 (hu)	2000-08-28
EP0932397B2 (en)	2014-04-02
AU4492697A (en)	1998-04-17
JP2001501209A (ja)	2001-01-30
SK38399A3 (en)	1999-09-10
DE69735497D1 (de)	2006-05-11
AU732985B2 (en)	2001-05-03
PT932397E (pt)	2006-07-31
NO991407D0 (no)	1999-03-23
AR009370A1 (es)	2000-04-12
CZ102799A3 (cs)	1999-07-14
BR9712125A (pt)	1999-08-31
WO1998013031A2 (en)	1998-04-02
KR20000048646A (ko)	2000-07-25
CA2266431A1 (en)	1998-04-02
NO991407L (no)	1999-03-23
MY130946A (en)	2007-07-31
EP0932397A2 (en)	1999-08-04
EP0932397B1 (en)	2006-03-15
HUP0000795A3 (en)	2000-09-28
GB9620187D0 (en)	1996-11-13
ID22523A (id)	1999-10-28
ATE320246T1 (de)	2006-04-15
ES2259447T3 (es)	2006-10-01
WO1998013031A3 (en)	1998-08-27
DE69735497T2 (de)	2006-08-24

Publication	Publication Date	Title
GB9612297D0 (en)	1996-08-14	Medicinal aerosol formulations
IL116460A0 (en)	1996-03-31	Aerosol drug formulations
GB9620187D0 (en)	1996-11-13	Medicinal aerosol formulations
ZA975883B (en)	1999-01-04	High dose liposomal aerosol formulations
GB9408117D0 (en)	1994-06-15	Pharmaceutical formulations
EG23826A (en)	2007-09-25	Pharmaceutical formulations
GB9713149D0 (en)	1997-08-27	Pharmaceutical formulations
ZA951781B (en)	1995-09-05	Pharmaceutical formulations
AP9600883A0 (en)	1997-01-31	Pharmaceutical formulations
IL128484A0 (en)	2000-01-31	Pharmaceutical aerosol composition
IL112897A0 (en)	1995-06-29	Aerosol drug formulations containing vitamin e
ZA96392B (en)	1996-08-29	Pharmaceutical formulations
GB9413542D0 (en)	1994-08-24	Pharmaceutical formulations
ZA9510754B (en)	1996-06-24	Aerosol drug formulations
GB9600887D0 (en)	1996-03-20	Aerosol formulations
ZA976038B (en)	1999-01-07	Medicinal aerosol solution formulation
GB9621531D0 (en)	1996-12-04	Pharmaceutical formulations
GB9606372D0 (en)	1996-06-05	Pharmaceutical formulations
GB9500978D0 (en)	1995-03-08	Pharmaceutical formulations
GB9414216D0 (en)	1994-08-31	Pharmaceutical formulations
GB9417953D0 (en)	1994-10-26	Pharmaceutical formulations
GB9426113D0 (en)	1995-02-22	Pharmaceutical formulations
GB9408151D0 (en)	1994-06-15	Pharmaceutical formulations
GB9408163D0 (en)	1994-06-15	Pharmaceutical formulations
GB9408164D0 (en)	1994-06-15	Pharmaceutical formulations